Nomura Holdings’s Vera Therapeutics VERA Stock Holding History

Nomura Holdings’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,905	Closed	-$600K	–	2047
2024 Q1	$600K	Buy	+13,905	New	+$496K	﹤0.01%	1217

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Nomura Holdings's VERA Position: Q2 2024 in Review

Nomura Holdings sold out of Vera Therapeutics (VERA) in Q2 2024, closing a stake of 13,905 shares — an estimated $600K sold.

Nomura Holdings first reported a position in VERA in Q1 2024 and held it in 1 quarter. The position peaked at $600K in Q1 2024. 171 funds tracked by Wall St. Rank hold VERA as of Q2 2024.

Nomura Holdings reported no remaining Vera Therapeutics position as of Q2 2024 after selling out during the quarter.
Nomura Holdings sold 13,905 Vera Therapeutics shares in Q2 2024, an estimated $600K.
Nomura Holdings first reported a position in Vera Therapeutics in Q1 2024 and held it in 1 quarter.
Nomura Holdings's Vera Therapeutics position peaked at $600K in Q1 2024.
171 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2024.

Based on Nomura Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.